APP, amyloid  precursor protein, is linked to the onset of Alzheimer's disease (AD). We have here found that transforming growth factor 2 (TGF2), but not TGF1, binds to APP. The binding affinity of TGF2 to APP is lower than the binding affinity of TGF2 to the TGF receptor. On binding to APP, TGF2 activates an APP-mediated death pathway via heterotrimeric G protein G o , c-Jun N-terminal kinase, NADPH oxidase, and caspase 3 and/or related caspases. Overall degrees of TGF2-induced death are larger in cells expressing a familial AD-related mutant APP than in those expressing wild-type APP. Consequently, superphysiological concentrations of TGF2 induce neuronal death in primary cortical neurons, whose one allele of the APP gene is knocked in with the V642I mutation. Combined with the finding indicated by several earlier reports that both neural and glial expression of TGF2 was upregulated in AD brains, it is speculated that TGF2 may contribute to the development of AD-related neuronal cell death.